11Feb 2020

VITAMIN D STATUS AND DIABETIC CONTROL: EGYPTIAN MULTICENTER STUDY

  • Department of Internal Medicine, Faculty of Medicine, Benha University, Egypt.
  • Department of Endocrinology and Metabolism, Helwan University, Egypt.
  • Department of Internal Medicine, Faculty of Medicine, Assiut University, Egypt.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Vitamin D (Vit D) deficiencymay be linked to the development of type 1 and type 2 diabetes mellitus (DM). Specific Vitamin D receptor (VDR) allelic variants have been linked totype-1 diabetes mellitus (T1DM) in many countries. However, in type 2 DM, Vitamin D deficiency leads to impaired insulin action and secretion in both animal models and humans. This study aims to determine the effect of low vitamin D on glycemic control in Egyptian patients with type 1and type 2 DM. Patients and Methods: This is a retrospective multi-centers study included280 diabetic patients (140 patients with type 1 DM, and 140 with type 2 DM). The patients' data were collected from the patients' medical files in the Diabetic Clinics and Internal Medicines Departments of 3 University hospitals (Benha, Helwan, and Assiut) in Egypt, including age, sex, BMI, onset and duration of DM, LDL-C, vitamin D, and HbA1c. Results: 50 (35.7%) type 1 diabetic patients had low vitamin D versus 110(78.6%) type 2 diabetic patients. The study revealed asignificant inverse correlation between the serum vitamin D level and HbA1c levelin patients with type 1 DM; but,in patients with type 2 DM,there was no significance correlation between serum vitamin D level and HbA1c level. Conclusion: low serum vitamin D level correlated inversely with the degree glycemic control in type 1 DM; but,such correlation had been failed to prove in patients with type 2 DM.Whether giving vitamin D supplementation to already vitamin D deficient diabetics will help to modulate the disease progression remains a debate.

  1. Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006;147(12):5542-8.
  2. van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. The Journal of steroid biochemistry and molecular biology. 2005;97(1-2):93-101.
  3. Lee S, Clark SA, Gill RK, Christakos S. 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion. Endocrinology. 1994;134(4):1602-10.
  4. Chakhtoura M, Azar ST. The role of vitamin d deficiency in the incidence, progression, and complications of type 1 diabetes mellitus. International journal of endocrinology. 2013;2013:148673.
  5. Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia. 2005;48(7):1247-57.
  6. Stadlmayr A, Aigner E, Huber-Schonauer U, Niederseer D, Zwerina J, Husar-Memmer E, et al. Relations of vitamin D status, gender and type 2 diabetes in middle-aged Caucasians. Acta diabetologica. 2015;52(1):39-46.
  7. Krul-Poel YH, Westra S, ten Boekel E, ter Wee MM, van Schoor NM, van Wijland H, et al. Effect of Vitamin D Supplementation on Glycemic Control in Patients With Type 2 Diabetes (SUNNY Trial): A Randomized Placebo-Controlled Trial. Diabetes care. 2015;38(8):1420-6.
  8. Sheth JJ, Shah A, Sheth FJ, Trivedi S, Lele M, Shah N, et al. Does vitamin D play a significant role in type 2 diabetes? BMC endocrine disorders. 2015;15:5.
  9. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. The Journal of clinical endocrinology and metabolism. 2011;96(7):1911-30.
  10. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Yakout SM, Aljohani NJ, et al. Lower vitamin D status is more common among Saudi adults with diabetes mellitus type 1 than in non-diabetics. BMC public health. 2014;14:153.
  11. Shih EM, Mittelman S, Pitukcheewanont P, Azen CG, Monzavi R. Effects of vitamin D repletion on glycemic control and inflammatory cytokines in adolescents with type 1 diabetes. Pediatric diabetes. 2016;17(1):36-43.
  12. Riyaz Ahmad Daga BAL, Zaffar Amin Shah,Shahnaz Ahmad Mir, Suman Kumar Kotwal, Abdul Hamid Zargar. High prevalence of vitamin D deficiency among newly diagnosed youth-onset diabetes mellitus in north India. Arquivos brasileiros de endocrinologia e metabologia. 2012;56/7.
  13. Mohr SB, Garland CF, Gorham ED, Garland FC. The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia. 2008;51(8):1391-8.
  14. Neu A, Kehrer M, Hub R, Ranke MB. Incidence of IDDM in German children aged 0-14 years. A 6-year population-based study (1987-1993). Diabetes care. 1997;20(4):530-3.
  15. Ogunkolade BW, Boucher BJ, Prahl JM, Bustin SA, Burrin JM, Noonan K, et al. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes. 2002;51(7):2294-300.
  16. Elsayed A. M. MGA. Vitamin D deficiency and its correlation to hemoglobin A1C in adolescent and young adult type 1 diabetes mellitus patients. AL-Azhar Assiut medical journal2015; 14 (2), 76-80)
  17. Nwosu BU, Stavre ZG, Maranda L, Cullen K, Lee MM. Hepatic dysfunction is associated with vitamin D deficiency and poor glycemic control in diabetes mellitus. Journal of pediatric endocrinology & metabolism : JPEM. 2012;25(1-2):181-6.
  18. Nwosu BU, Maranda L. The effects of vitamin D supplementation on hepatic dysfunction, vitamin D status, and glycemic control in children and adolescents with vitamin D deficiency and either type 1 or type 2 diabetes mellitus. PloS one. 2014;9(6):e99646.
  19. Pitocco D, Crino A, Di Stasio E, Manfrini S, Guglielmi C, Spera S, et al. The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Diabetic medicine : a journal of the British Diabetic Association. 2006;23(8):920-3.
  20. Aljabri KS, Bokhari SA, Khan MJ. Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiency. Annals of Saudi medicine. 2010;30(6):454-8.
  21. Greenbaum CJ. Insulin resistance in type 1 diabetes. Diabetes/metabolism research and reviews. 2002;18(3):192-200.
  22. Harinarayan CV. Vitamin D and diabetes mellitus. Hormones. 2014;13(2):163-81.
  23. McGill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutrition journal. 2008;7:4.
  24. George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabetic medicine : a journal of the British Diabetic Association. 2012;29(8):e142-50.
  25. Fujita T, Palmieri GM. Calcium paradox disease: calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload. Journal of bone and mineral metabolism. 2000;18(3):109-25.
  26. Luo C, Wong J, Brown M, Hooper M, Molyneaux L, Yue DK. Hypovitaminosis D in Chinese type 2 diabetes: lack of impact on clinical metabolic status and biomarkers of cellular inflammation. Diabetes & vascular disease research. 2009;6(3):194-9.

[Amira M. Elsayed MD, Ali Hasaneen MD, Eman Mohamed Fahmy MD and Ghada A. Mohamed MD (2020); VITAMIN D STATUS AND DIABETIC CONTROL: EGYPTIAN MULTICENTER STUDY Int. J. of Adv. Res. 8 (Feb). 939-944] (ISSN 2320-5407). www.journalijar.com

Amira M. Elsayed MD
Department of Internal Medicine, Faculty of Medicine, Benha University. Egypt

DOI:

Article DOI: 10.21474/IJAR01/10528      
DOI URL: https://dx.doi.org/10.21474/IJAR01/10528

Download Full Paper

Download PDF No. of Downloads: 9 | No. of Views: 37